Intel's Foundry Revenue Gap: A $528 Billion Market Cap With $174 Million in Customer Chip Sales
Published on 07/06/2026 at 15:13 | Redaktion boerse-global.de
The numbers tell a story that the stock price has been trying to outrun. Intel's shares closed Monday at €108.94, barely below Friday's €109.10, after a week that saw them shed 5.50%. On a normal stock that would rattle investors. On Intel, it passes for noise — and that is precisely the problem.
The chipmaker's market capitalization now stands at €528.61 billion, a valuation built almost entirely on the promise that its external foundry business will one day be enormous. So far, that business has generated just $174 million in first-quarter revenue. The gap between narrative and reality is measured in billions, and last week it spooked the market. Chip stocks were sold broadly, but Intel absorbed the heaviest blows across multiple sessions.
What has propelled the stock is a combination of hope and headlines. A report that Intel had reached a preliminary agreement to manufacture chips for Apple ignited the most powerful leg of the rally — but the Wall Street Journal noted it was only a tentative understanding, not a signed contract. Taiwan Semiconductor remains Apple's primary supplier. The distance between a handshake and a firm order is exactly the distance that has tripped up Intel's foundry ambitions before.
A lone bull versus the consensus
Against this backdrop, HSBC analyst Frank Lee stands largely alone. He doubled his price target from $100 to $200 and reiterated a buy rating, arguing that Intel's foundry division has become "too good to ignore." Lee expects new business leads to translate into real orders from the second half of 2026. That timeline aligns with Intel's own critical inflection point: the 18A process node, which must achieve yield targets in the first half of 2026 before the company can take on external customers.
Should investors sell immediately? Or is it worth buying Intel?
The broader analyst community is far less convinced. The average price target sits at €86.08, implying roughly 21% downside from current levels. That gap between HSBC's euphoria and the skeptical consensus mirrors the second gap — the one between Intel's stock market performance and the foundry business that is supposed to justify it.
Technicals tell a story of momentum gone extreme
The rally has been extraordinary by any measure. Intel shares have surged 224.18% since the start of the year and 480.70% over the past twelve months. Even after last week's pullback, the stock trades 106.17% above its 200-day moving average of €53.33. The 50-day average of €101.21 sits well below the current price — a sign of how rapidly the advance has accelerated.
Yet the relative strength index reads 51.7, neutral territory that indicates neither overbought nor oversold conditions. The annualized 30-day volatility of 89.07% suggests the calm is deceptive. The stock is digesting a massive move in an environment where every headline triggers a reaction.
The recent denial of rumors that Intel had discussed a state stake with Anthropic or that the Trump administration was negotiating a similar arrangement with OpenAI underscores the market's hunger for any AI-linked narrative. Intel was forced to publicly dismiss speculation that had never been confirmed in the first place.
Government money and the politics of ownership
The CHIPS Act grant that the US government converted into roughly a 10% stake in Intel last August has become an unexpected reference point in a much larger debate. Reports that OpenAI considered offering Washington a 5% stake — and that the concept might be extended to other AI labs — immediately drew comparisons to Intel's government investment. But the comparison is flawed. Intel took public money because it needed capital and had little bargaining power. The AI labs, sitting on mountains of cash, would negotiate from strength. Intel's case emerged from weakness and was turned into a windfall by the stock's rally.
Intel at a turning point? This analysis reveals what investors need to know now.
That rally has also forced the company to confront uncomfortable questions about its own technology roadmap. CFO David Zinsner recently acknowledged that Intel is reconsidering whether to offer 18A and the newer 14A process simultaneously to external foundry clients. More tellingly, over 90% of Intel's Nova Lake desktop CPUs are being built on TSMC's N2 process, not in Intel's own fabs. The message is subtle but unmistakable: even Intel's own products rely on the competition.
The next two weeks decide the narrative
Intel is pushing ahead with physical expansion. Ground was broken on the Santa Clara facility expansion during the same turbulent trading days, a facility meant to handle both 18A and 14A production. But the market is now less interested in shovels than in bookings.
The second-quarter earnings report, due in little more than two weeks, will be the first real test of whether the foundry story is generating tangible revenue or remains a compelling fiction. The stock has priced in a successful turnaround that has not yet materialized on the income statement. If the numbers disappoint, the gap between €528 billion and $174 million will become much harder to ignore.
Ad
Intel Stock: New Analysis - 6 July
Fresh Intel information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
